Center of Excellence in Higher Education
The First Private University in Bangladesh

Dr. Md Shaki Mostaid

Full Time Faculty
Assistant Professor

Ph.D., (Pharmacogenetics), University of Melbourne, Australia;
M.Pharm (Clinical Pharmacy and Pharmacology), University of Dhaka, Bangladesh

Phone: +880-2-55668200 Ext: 6436
Email: shaki.mostaid@northsouth.edu
Office: SAC-1069

Curriculum Vitae

 

 

Dr. Md. Shaki Mostaid joined the Department of Pharmaceutical Sciences, North South University in January, 2021. Prior to that he served as an Assistant Professor at the Department of Pharmacy, Brac University. He completed his PhD from the Department of Psychiatry, University of Melbourne, Australia in 2018. His doctoral studies involved identifying suitable blood biomarkers for treatment-resistant schizophrenia using genomic, transcriptomic, and proteomic analysis tools. Following this he was awarded the Harley Hotchkiss Samuel Weiss Postdoctoral Research Fellowship to pursue postdoctoral training at the Department of Medical Genetics, University of Calgary, Canada. His doctoral and postdoctoral works led to several internal publications among which 5 are in nature research journal group. His research area focuses on genomic, transcriptomic and proteomic analysis of candidate genes for suitable biomarkers in various mental health disorders specially schizophrenia and depression. Prior to the doctoral studies, Dr. Mostaid completed his Bachelor of Pharmacy (Honors) and Masters of Pharmacy from the Department of Pharmacy, University of Dhaka. He also worked as a lecturer at the Department of Pharmacy, Northern University Bangladesh.

  1. Mostaid MS, Mancuso SG, Liu C, Sundram S, Pantelis C, Everall IP et al. Meta-analysis reveals associations between genetic variation in the 5' and 3' regions of Neuregulin-1 and schizophrenia. Translational psychiatry 2017; 7(1): e1004.
  2. Mostaid MS, Ahmed MU, Islam MS, Bin Sayeed MS, Hasnat A. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi Tumour Biol 2014; 35(10): 10309-10317.
  3. Mostaid MS, Lee T, Chana G, Sundram S, Weickert CS, Pantelis C, Everall IP et al. Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients. (Accepted on 23rd September, 2017 to Translational Psychiatry).
  4. Mostaid MS, Lee T, Chana G, Sundram S, Weickert CS, Pantelis C, Everall IP et al. Peripheral transcription of NRG-ErbB pathway downstream signaling genes is upregulated in patients with treatment-resistant schizophrenia. Frontiers in Psychiatry, 2017, 8 (225).
  5. Chau EJ*, Mostaid MS*, Bousman CA, Everall IP et al. Downregulation of SELENBP1 protein in plasma in patients with first episode psychosis but not in treatment-resistant schizophrenia. Progress in Neuropsychopharmacology and biological psychiatry 2018, 85 (1-6).
  6. Saini SM, Mancuso S, Mostaid MS, Everall IP, Bousman CA et al. Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. (Accepted on 20th June, 2017 to Translational Psychiatry).
  7. Bousman CA, Lee TY, Kim M, Lee J, Mostaid MS, Bang M et al. Genetic variation in cytokine genes and risk for psychosis transition among individuals at ultra-high risk for psychosis. (Accepted on 26th July in Schizophrenia Research).
  8. Bousman CA, Cropley V, Klauser P, Hess J, Pereira A, Idrizi R, Bruggemann J, Mostaid MS, Lenroot R et al. Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia (Accepted on 6th July, 2017 in  Psychological Medicine).
  9. Bousman CA, Luza S, Mancuso SG, Kang D, Opazo CM, Mostaid MS, et al. Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia. Scientific Reports 2019, 9(1), 2307.
  10. MS Mostaid, Pantelis C, Everall I, Bousman CA. Decreased peripheral TNF alpha (TNF-a) mRNA expression in patients with treatment-resistant schizophrenia. Schizophrenia research 2018, 202 (387-388).
  11. Mostaid MS, Dimitrakopoulos S, Wannan C, Cropley V, Weickert CS et al. An interleukin-1 beta (IL1B) haplotype linked with psychosis transition is associated with IL1B gene expression and brain structure. Schizophrenia research 2018, in press.
  12. Bashar T, Apu MNH, Mostaid MS, Islam MS, Hasnat A. Pharmacokinetics and bioavailability study of a prednisolone tablet as a single oral dose in Bangladeshi healthy volunteers. Dose response 2018, 16(3), 1559325818783932.
  13. Meiklejohn H*, Mostaid MS*, Luza S, Mancuso S, Everall IP, Bousman CA. Blood and brain levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophrenia. Journal of Psychiatric Research 113 (2019) 51-57.
  14. Liu C, Kanazawa T, Tian Y, Mohamed Saini S, Mancuso S, MostaidMS, Takahashi A, Zhang D, Zhang F, Yu H, Doo Shin H, Sub Cheong H, Ikeda M, Kubo M, Iwata N, Woo SI, Yue W, Kamatani Y, Shi Y, Li Z, Everall I, Pantelis C, Bousman C. The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies. Transl Psychiatry. 2019 Aug 27;9(1):205. doi: 10.1038/s41398-019-0532-4.

2019-21

2014-17

Harley-Hotchkiss Samuel Weiss Postdoctoral Fellowship, University of Calgary, AB, Canada.

Melbourne International Fee Remission Scholarship (MIFRS) awarded by the University of Melbourne for PhD.

2014-17

Melbourne International Research Scholarship (MIRS) awarded by the University of Melbourne as stipend for PhD.

2014-17

CRC for Mental Health top-up scholarship for research.

2013-14

National Science and Technology Fellowship (NSTF) awarded by the Ministry of   Science and Technology, Government of the People’s Republic of Bangladesh.

2008-12

Board scholarship for higher secondary school certificate examination result.

2006-08

Board scholarship for secondary school certificate examination result.

 

 

 

 

  1. PhD (Pharmacogenetics), University of Melbourne, Australia (2014-2018).
  2. M.Pharm (Clinical Pharmacy and Pharmacology: 1st position), University of Dhaka (2012-13).
  3. B.Pharm (Hons: 4th position), Faculty of Pharmacy, University of Dhaka (2007-2011).
  4. H.S.C (GPA 5.0), Notre Dame College, Dhaka (2007)
  5. S.S.C (GPA 5.0), Ideal School and College, Motijheel, Dhaka (2005)

 

  • Assistant Professor, Department of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh (January 2021-present)
  • Assistant Professor, Department of Pharmacy, Brac University, Dhaka, Bangladesh (June 2019-December 2020)
  • Post-doctoral Research Fellow, Department of Medical Genetics, University of Calgary, Alberta, Canada (September 2018-February 2019).
  • Lecturer, Department of Pharmacy, Northern University, Bangladesh (March 2013-May 2014)

N/A

Pharmaceutical Technology, Biopharmaceutics, Clinical Pharmacokinetics, Pharmacovigilance, Advanced Pharmacology

1. Biological Psychiatry-Australia

2. Bangladesh Pharmacy Council

Pharmacogenetics, genetic epidemiology, pharmacology, biomarker discovery